Variant report

Variant	nsv904186
Chromosome Location	chr15:45394406-45434493
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:1174)
CpG islands
(count:3606)
Chromatin interactive
region (count:34)
LncRNA
region (count:4)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:1174 , 50 per page) page: 1 2 3 4 5 6 7 ... 24

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr15:45423781-45424095	HepG2	liver:	n/a	n/a
2	ARID3A	chr15:45418662-45419119	K562	blood:	n/a	n/a
3	ARID3A	chr15:45418745-45419155	HepG2	liver:	n/a	n/a
4	ARID3A	chr15:45414357-45414389	HepG2	liver:	n/a	n/a
5	ARID3A	chr15:45410346-45410617	HepG2	liver:	n/a	n/a
6	ATF3	chr15:45410310-45410641	K562	blood:	n/a	n/a
7	BACH1	chr15:45408630-45409090	H1-hESC	embryonic stem cell:	n/a	n/a
8	BACH1	chr15:45424869-45424892	H1-hESC	embryonic stem cell:	n/a	n/a
9	BACH1	chr15:45421066-45421370	H1-hESC	embryonic stem cell:	n/a	n/a
10	BACH1	chr15:45410343-45410746	H1-hESC	embryonic stem cell:	n/a	n/a
11	BACH1	chr15:45406429-45406479	H1-hESC	embryonic stem cell:	n/a	n/a
12	BACH1	chr15:45404699-45405166	H1-hESC	embryonic stem cell:	n/a	n/a
13	BATF	chr15:45413200-45413678	GM12878	blood:	n/a	n/a
14	BATF	chr15:45413226-45413597	GM12878	blood:	n/a	n/a
15	BCL11A	chr15:45413347-45413584	GM12878	blood:	n/a	n/a
16	BCL11A	chr15:45413229-45413657	GM12878	blood:	n/a	n/a
17	BCLAF1	chr15:45410225-45410681	GM12878	blood:	n/a	n/a
18	BHLHE40	chr15:45410307-45410689	K562	blood:	n/a	n/a
19	BHLHE40	chr15:45418905-45419058	K562	blood:	n/a	n/a
20	BHLHE40	chr15:45427134-45427453	GM12878	blood:	n/a	n/a
21	BHLHE40	chr15:45431833-45431914	K562	blood:	n/a	n/a
22	BRCA1	chr15:45410328-45410576	HepG2	liver:	n/a	n/a
23	BRCA1	chr15:45410288-45410598	Hela-S3	cervix:	n/a	n/a
24	BRCA1	chr15:45410199-45410601	H1-hESC	embryonic stem cell:	n/a	n/a
25	BRCA1	chr15:45419959-45419986	Hela-S3	cervix:	n/a	n/a
26	CBX3	chr15:45410245-45410756	K562	blood:	n/a	n/a
27	CCNT2	chr15:45410102-45410648	K562	blood:	n/a	n/a
28	CEBPB	chr15:45414326-45414523	HepG2	liver:	n/a	n/a
29	CEBPB	chr15:45417073-45417182	HepG2	liver:	n/a	chr15:45417142-45417153
30	CEBPB	chr15:45414226-45414584	IMR90	lung:	n/a	n/a
31	CEBPB	chr15:45410369-45410627	H1-hESC	embryonic stem cell:	n/a	n/a
32	CHD1	chr15:45410274-45410565	H1-hESC	embryonic stem cell:	n/a	n/a
33	CHD1	chr15:45405290-45405311	H1-hESC	embryonic stem cell:	n/a	n/a
34	CHD2	chr15:45410333-45410533	HepG2	liver:	n/a	n/a
35	CHD2	chr15:45410268-45410629	Hela-S3	cervix:	n/a	n/a
36	CHD2	chr15:45410373-45410701	K562	blood:	n/a	n/a
37	CHD2	chr15:45418847-45418906	K562	blood:	n/a	n/a
38	CHD2	chr15:45410323-45410684	H1-hESC	embryonic stem cell:	n/a	n/a
39	CREB1	chr15:45410301-45410535	A549	lung:	n/a	n/a
40	CREB1	chr15:45410285-45410715	H1-hESC	embryonic stem cell:	n/a	n/a
41	CREB1	chr15:45410227-45410753	H1-hESC	embryonic stem cell:	n/a	n/a
42	CTBP2	chr15:45426981-45427713	H1-hESC	embryonic stem cell:	n/a	n/a
43	CTBP2	chr15:45404577-45407347	H1-hESC	embryonic stem cell:	n/a	n/a
44	CTBP2	chr15:45421049-45422126	H1-hESC	embryonic stem cell:	n/a	n/a
45	CTBP2	chr15:45408486-45409537	H1-hESC	embryonic stem cell:	n/a	n/a
46	CTCF	chr15:45402540-45402690	AG04450	lung:	n/a	n/a
47	CTCF	chr15:45410920-45411070	GM12864	blood:	n/a	n/a
48	CTCF	chr15:45418880-45419030	NHEK	skin:	n/a	chr15:45418939-45418957
49	CTCF	chr15:45410380-45410530	GM12801	blood:	n/a	n/a
50	CTCF	chr15:45427574-45427833	NHEK	skin:	n/a	n/a

(count:3606 , 50 per page) page: 1 2 3 4 5 6 7 ... 73

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr15:45421068-45421118	RPTEC	kidney:	n/a
2	chr15:45434285-45434335	SK-N-MC	brain:	n/a
3	chr15:45406706-45406756	SK-N-SH	brain:	n/a
4	chr15:45404896-45404946	BE2_C	brain:	n/a
5	chr15:45406486-45406536	HCM	heart:	n/a
6	chr15:45427034-45427084	U87	brain:	n/a
7	chr15:45421578-45421628	HUVEC	blood vessel:	n/a
8	chr15:45421068-45421118	RPTEC	kidney:	n/a
9	chr15:45434285-45434335	SK-N-MC	brain:	n/a
10	chr15:45406706-45406756	SK-N-SH	brain:	n/a
11	chr15:45404896-45404946	BE2_C	brain:	n/a
12	chr15:45406486-45406536	HCM	heart:	n/a
13	chr15:45427034-45427084	U87	brain:	n/a
14	chr15:45421578-45421628	HUVEC	blood vessel:	n/a
15	chr15:45410236-45410286	PrEC	prostate:	n/a
16	chr15:45403733-45403783	PANC-1	pancreas:	n/a
17	chr15:45406477-45406527	H1-hESC	embryonic stem cell:	embryo
18	chr15:45421068-45421118	HEEpiC	esophagus:	n/a
19	chr15:45406477-45406527	HPAEpiC	pulmonary alveolar:	n/a
20	chr15:45406866-45406916	LNCaP	prostate:	n/a
21	chr15:45405103-45405153	HEK293	kidney:	embryo
22	chr15:45403733-45403783	CMK	blood:	n/a
23	chr15:45404157-45404207	GM12892	blood:	n/a
24	chr15:45406362-45406412	Hepatocyte	liver:	n/a
25	chr15:45434285-45434335	PrEC	prostate:	n/a
26	chr15:45421860-45421910	HAEpiC	amniotic membrane:	n/a
27	chr15:45408574-45408624	HCM	heart:	n/a
28	chr15:45422371-45422421	NT2-D1	testis:	n/a
29	chr15:45406477-45406527	HRCEpiC	kidney:	n/a
30	chr15:45427577-45427627	NHDF-neo	bronchial:	n/a
31	chr15:45412590-45412640	HIPEpiC	eye:	n/a
32	chr15:45422393-45422443	H1-hESC	embryonic stem cell:	embryo
33	chr15:45412590-45412640	BJ	skin:	n/a
34	chr15:45421951-45422001	IMR90	lung:	fetal
35	chr15:45410236-45410286	HAEpiC	amniotic membrane:	n/a
36	chr15:45417414-45417464	GM06990	blood:	n/a
37	chr15:45406866-45406916	Hela-S3	cervix:	n/a
38	chr15:45421612-45421662	GM12891	blood:	n/a
39	chr15:45427297-45427347	BE2_C	brain:	n/a
40	chr15:45406486-45406536	HPAEpiC	pulmonary alveolar:	n/a
41	chr15:45421578-45421628	A549	lung:	n/a
42	chr15:45412590-45412640	GM12892	blood:	n/a
43	chr15:45406931-45406981	GM12891	blood:	n/a
44	chr15:45402305-45402355	MCF-7	breast:	n/a
45	chr15:45412590-45412640	HAEpiC	amniotic membrane:	n/a
46	chr15:45406362-45406412	BJ	skin:	n/a
47	chr15:45421998-45422048	IMR90	lung:	fetal
48	chr15:45422325-45422375	Jurkat	blood:	n/a
49	chr15:45406327-45406377	HCF	heart:	n/a
50	chr15:45421860-45421910	BJ	skin:	n/a

(count:34 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr15:45410580..45412317-chr15:45415759..45418660,2	K562	blood:
2	chr15:45409886..45410591-chr15:45421620..45422120,2	K562	blood:
3	chr15:45418525..45419261-chr15:45568782..45569294,2	K562	blood:
4	chr15:45145307..45146142-chr15:45409718..45410518,2	K562	blood:
5	chr15:45407575..45409990-chr15:45413703..45415541,2	K562	blood:
6	chr15:45417539..45419456-chr15:45453596..45456552,2	K562	blood:
7	chr15:45413253..45416460-chr15:45420165..45423361,4	K562	blood:
8	chr15:45431968..45434188-chr15:45440208..45442818,2	K562	blood:
9	chr15:45402172..45404057-chr15:45407808..45410481,2	MCF-7	breast:
10	chr15:45418967..45421770-chr15:45423953..45425588,2	K562	blood:
11	chr15:45410636..45412600-chr15:45463074..45466007,2	K562	blood:
12	chr15:45412250..45414388-chr15:45434468..45436699,2	K562	blood:
13	chr15:45418671..45419337-chr15:45497010..45497531,2	K562	blood:
14	chr15:45410032..45410581-chr15:45418687..45419353,3	MCF-7	breast:
15	chr15:45402965..45405384-chr15:45407818..45410560,2	K562	blood:
16	chr15:45424906..45427712-chr15:45434989..45436687,2	MCF-7	breast:
17	chr15:45394002..45396843-chr15:45411789..45413686,2	K562	blood:
18	chr15:45412250..45414388-chr15:45434468..45436699,2	K562	blood:
19	chr15:45402965..45405384-chr15:45407818..45410560,2	K562	blood:
20	chr15:45410026..45410941-chr15:45568756..45569289,2	MCF-7	breast:
21	chr15:45434203..45436552-chr15:45443104..45444699,2	K562	blood:
22	chr15:45413253..45416460-chr15:45420165..45423361,4	K562	blood:
23	chr15:45411733..45414237-chr15:45457948..45460622,2	MCF-7	breast:
24	chr15:45421458..45423929-chr15:45425616..45427785,3	K562	blood:
25	chr15:45390867..45394764-chr15:45395699..45399424,4	K562	blood:
26	chr15:45418967..45421770-chr15:45423953..45425588,2	K562	blood:
27	chr15:45409152..45412317-chr15:45414366..45418660,3	K562	blood:
28	chr15:45410580..45412317-chr15:45415759..45418660,2	K562	blood:
29	chr15:45419682..45422492-chr15:45439633..45442095,2	K562	blood:
30	chr15:45410032..45410581-chr15:45418687..45419353,3	MCF-7	breast:
31	chr15:45402172..45404057-chr15:45407808..45410481,2	MCF-7	breast:
32	chr15:45409132..45413033-chr15:45458233..45460669,3	MCF-7	breast:
33	chr15:45380073..45381960-chr15:45400521..45403354,2	K562	blood:
34	chr15:45393110..45394732-chr15:45395329..45397612,2	K562	blood:

(count:4 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-DUOX2-3	chr15:45421371-45421813	NONHSAT042218
2	lnc-DUOX2-3	chr15:45422021-45422078	NONHSAT042217
3	lnc-DUOX2-3	chr15:45422050-45422075	NONHSAT042218
4	lnc-DUOX2-3	chr15:45421353-45421813	NONHSAT042217

No data

Variant related genes	Relation type
DUOX1	TF binding region
DUOX2	TF binding region
DUOXA2	TF binding region
DUOXA1	TF binding region
DUOX1	CpG island
DUOX2	CpG island
DUOXA2	CpG island
DUOXA1	CpG island
ENSG00000259539	chromatin interactions
ENSG00000140279	chromatin interactions
ENSG00000137857	chromatin interactions
ENSG00000138606	chromatin interactions
ENSG00000140254	chromatin interactions

Extended variants
information (count: 1855 )
Associated
traits (count: 65 )

Variant overlapped rSNPs/rCNVs (count:1855 , 50 per page) page: 1 2 3 4 5 6 7 ... 38

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs269866	chr15:45394406-45394407	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs570895540	chr15:45394456-45394457	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs534821142	chr15:45394467-45394468	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
4	rs374974760	chr15:45394468-45394469	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
5	rs57482502	chr15:45394471-45394472	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
6	rs552906576	chr15:45394496-45394497	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs116562151	chr15:45394519-45394520	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
8	rs269865	chr15:45394550-45394551	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
9	rs574492949	chr15:45394572-45394573	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
10	rs563676971	chr15:45394577-45394578	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
11	rs111477569	chr15:45394583-45394584	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
12	rs549384525	chr15:45394598-45394599	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
13	rs565917260	chr15:45394669-45394670	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs188925579	chr15:45394722-45394723	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs551609936	chr15:45394754-45394755	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs557218014	chr15:45394782-45394783	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs571723704	chr15:45394793-45394794	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs112473943	chr15:45394812-45394813	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs557185506	chr15:45394841-45394842	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs574032758	chr15:45394915-45394916	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs56838826	chr15:45394921-45394922	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
22	rs552571799	chr15:45394950-45394951	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs572771500	chr15:45394951-45394952	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs564544328	chr15:45394962-45394963	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs572857523	chr15:45394965-45394966	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs544942583	chr15:45394966-45394967	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs191896845	chr15:45394977-45394978	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs574983606	chr15:45395047-45395048	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs543652500	chr15:45395053-45395054	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs563517889	chr15:45395075-45395076	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs372461725	chr15:45395094-45395095	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs529624353	chr15:45395135-45395136	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs549429299	chr15:45395172-45395173	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs184374327	chr15:45395178-45395179	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs189714805	chr15:45395195-45395196	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs140875545	chr15:45395246-45395247	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs181347911	chr15:45395264-45395265	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs371001731	chr15:45395270-45395271	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs144319633	chr15:45395421-45395422	Bivalent Enhancer Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
40	rs550823387	chr15:45395428-45395429	Bivalent Enhancer Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
41	rs374639591	chr15:45395438-45395439	Bivalent Enhancer Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
42	rs567453390	chr15:45395443-45395444	Bivalent Enhancer Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
43	rs377264943	chr15:45395446-45395447	Bivalent Enhancer Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
44	rs536417264	chr15:45395452-45395453	Bivalent Enhancer Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
45	rs185993301	chr15:45395465-45395466	Bivalent Enhancer Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
46	rs377240896	chr15:45395475-45395476	Bivalent Enhancer Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
47	rs573052608	chr15:45395506-45395507	Bivalent Enhancer Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
48	rs538296353	chr15:45395570-45395571	Bivalent Enhancer Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
49	rs61626661	chr15:45395584-45395585	Bivalent Enhancer Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
50	rs151160891	chr15:45395607-45395608	Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:65)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Schizophrenia	19415332	CNVD
Breast cancer	22522925	CNVD
Autism	22495311	CNVD
Wilms tumour	21544195	CNVD
Testicular germ cell tumor	18059402	CNVD
cataract	16735990	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Medulloblastoma	21979893	CNVD
spastic paraplegia with thinning of corpus callosum	19105190	CNVD
Schizophrenia	21324950	CNVD
Astrocytoma	17387387	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Disease	21824424	CNVD
Melanoma	18172304	CNVD
Colorectal cancer	16774939	CNVD
Gastric cancer	17167181	CNVD
Neuroblastoma	19435921	CNVD
Colorectal cancer	19359472	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Colorectal cancer	16272173	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Multiple myeloma	17550852	CNVD
Intellectual disability	22102821	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute myeloid leukemia	20729466	CNVD
Prostate cancer	16573809	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Multiple myeloma	20724749	CNVD
Lung cancer	18438408	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	21785460	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Ovarian cancer	22174824	CNVD
Prostate cancer	18632612	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Basal cell lymphoma	17053054	CNVD
Cancer	21129771	CNVD
Papillary thyroid carcinoma	22161024	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Breast cancer	21045282	CNVD
Breast cancer	22032731	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Gastrointestinal stromal cancer	20877625	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Myelofibrosis	22110671	CNVD
Hirschsprung''s Disease	21712996	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Breast cancer	16272173	CNVD
Hepatocellular carcinoma	16750200	CNVD
Abnormal phenotypes	18644119	CNVD
Cancer	16751803	CNVD
Melanoma	17363583	CNVD
Acute myeloid leukemia	19651601	CNVD
Marfan syndrome	17492313	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:1357 , 50 per page) page: 1 2 3 4 5 6 7 ... 28

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr15:45363800-45398400	Weak transcription	Gastric	stomach
2	chr15:45381400-45404600	Weak transcription	Right Atrium	heart
3	chr15:45383400-45395200	Weak transcription	Colonic Mucosa	Colon
4	chr15:45391600-45395200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
5	chr15:45393800-45395200	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
6	chr15:45393800-45395600	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
7	chr15:45394000-45394800	Enhancers	Esophagus	oesophagus
8	chr15:45394200-45398600	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
9	chr15:45394400-45394600	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
10	chr15:45394400-45394600	Enhancers	Stomach Mucosa	stomach
11	chr15:45394600-45396200	Weak transcription	Stomach Mucosa	stomach
12	chr15:45394800-45398800	Weak transcription	Esophagus	oesophagus
13	chr15:45395200-45395400	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
14	chr15:45395200-45397800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
15	chr15:45395400-45395800	Bivalent Enhancer	H9 Derived Neuron Cultured Cells	ES cell derived
16	chr15:45395400-45396200	Enhancers	Fetal Adrenal Gland	Adrenal Gland
17	chr15:45395600-45395800	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
18	chr15:45396200-45396400	Enhancers	Stomach Mucosa	stomach
19	chr15:45396400-45397200	Weak transcription	Stomach Mucosa	stomach
20	chr15:45397200-45397800	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
21	chr15:45397200-45398000	Enhancers	Stomach Mucosa	stomach
22	chr15:45397800-45401200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
23	chr15:45398400-45400400	Strong transcription	Gastric	stomach
24	chr15:45398600-45399200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
25	chr15:45398800-45399200	Bivalent Enhancer	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
26	chr15:45398800-45399200	Strong transcription	Esophagus	oesophagus
27	chr15:45399000-45399200	Bivalent Enhancer	HUES6 Cell Line	embryonic stem cell
28	chr15:45399000-45399200	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
29	chr15:45399200-45400600	Weak transcription	Esophagus	oesophagus
30	chr15:45399400-45399600	Bivalent Enhancer	H1 Derived Mesenchymal Stem Cells	ES cell derived
31	chr15:45399400-45399600	Bivalent Enhancer	Stomach Mucosa	stomach
32	chr15:45400400-45400600	Flanking Bivalent TSS/Enh	H1 Derived Mesenchymal Stem Cells	ES cell derived
33	chr15:45400400-45400600	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
34	chr15:45400400-45400800	Genic enhancers	Gastric	stomach
35	chr15:45400600-45400800	Enhancers	Esophagus	oesophagus
36	chr15:45400800-45402200	Weak transcription	Gastric	stomach
37	chr15:45401200-45401400	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
38	chr15:45401200-45401400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
39	chr15:45402200-45402800	Enhancers	Gastric	stomach
40	chr15:45402400-45403200	Bivalent Enhancer	iPS DF 19.11 Cell Line	embryonic stem cell
41	chr15:45402600-45402800	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
42	chr15:45402600-45402800	Bivalent Enhancer	Primary T killer naive cells fromperipheralblood	blood
43	chr15:45402600-45402800	Bivalent Enhancer	Skeletal Muscle Female	skeletal muscle
44	chr15:45402800-45403000	Bivalent Enhancer	Primary B cells from peripheral blood	blood
45	chr15:45402800-45403000	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
46	chr15:45402800-45403800	Weak transcription	Gastric	stomach
47	chr15:45403600-45403800	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin03	Skin
48	chr15:45403600-45404000	Enhancers	Lung	lung
49	chr15:45403600-45404200	Bivalent Enhancer	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
50	chr15:45403600-45404200	Flanking Bivalent TSS/Enh	iPS DF 19.11 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links